Irish-tax registered pharmaceutical company which generates most of its income from the US healthcare system. Formerly Actavis. Acquired Forest Laboratories in 2014, and Allergan Inc in 2015. Sold its generics business to Teva in 2016.
In 2018, the Carbon Disclosure Project (CDP) asked companies to provide data about their efforts to reduce greenhouse gas emissions and mitigate climate change risk. Responding companies are scored across four key areas: disclosure; awareness; management; and leadership. This company received a CDP Climate Change Score of B-.
[Source 2018][More on Climate Change]
This company received a SAM Rank of 65/100 in the Pharmaceuticals category of the 2018 SAM Corporate Sustainability Assessment. The index is based on an analysis of corporate economic, environmental and social performance, assessing issues such as corporate governance, risk management, environmental reporting, climate strategy, human rights and labour practices.
[Source 2018][More on Sustainability Reporting]
In 2018, the Carbon Disclosure Project (CDP) asked companies to provide data about their efforts to manage and govern freshwater resources. Responding companies are scored on six key metrics: transparency; governance & strategy; measuring & monitoring; risk assessment; targets & goals; and value chain engagement. This company received a CDP Water Security Score of C.
[Source 2018][More on Human Rights]
|Company Structure||Public company|
|Revenue||US$15.8 billion in 2018|
|# Employees||17,800 in 2018|
|Subsidiaries||Forest Laboratories Inc|